Exogenous prostaglandin E2 inhibits TPA induced matrix metalloproteinase-9 production in MCF-7 cells

Prostaglandins and Other Lipid Mediators

Volumn 73, Issue 3-4, 2004, Pages 237-247

  Reno F ^a   Baj, G ^a   Surico, N ^a   Cannas, M ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Breast cancer; EP4; MCF 7; Metastasis; MMP 9; PGE2; TPA

Indexed keywords

GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; COLLAGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EP4 RECEPTOR; LAMININ; MATRIGEL; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEOGLYCAN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; ZYMOGRAPHY; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME INDUCTION; METASTASIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; DRUG COMBINATIONS; ENZYME ACTIVATION; ENZYME INDUCTION; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; PROTEOGLYCANS; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; TETRADECANOYLPHORBOL ACETATE;

EID: 2942511447     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2004.03.002     Document Type: Article

References (41)

1. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:2003;827
2. Davies B., Miles D.W., Happerfield L.C., Naylor M.S., Bobrow L.G., Rubens R.D., et al. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer. 67:1993;1126
3. Doerr M.E., Jones J.I. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271:1996;2443
4. Iwata H., Kobayashi S., Iwase H., Masaoka A., Fujimoto N., Okada Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn. J. Cancer Res. 87:1996;602
5. Mira E., Manes S., Lacalle R.A., Marquez G., Martinez A.C. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology. 140:1999;1657
6. Liu J.F., Crepin M., Liu J.M., Barritault D., Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun. 293:2002;1174
7. Yao J., Xiong S., Klos K., Nguyen N., Grijalva R., Li P., et al. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene. 20:2001;8066
8. Johnson M.D., Torri J.A., Lippman M.E., Dickson R.B. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res. 247:1999;105
9. Watson D.M., Kelly R.W., Miller W.R. Prostaglandins and prognosis in human breast cancer. Br. J. Cancer. 56:1987;367
10. Smith W.L., Meade E.A., DeWitt D.L. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann. N.Y. Acad. Sci. 714:1994;136
11. Wu K.K. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. J. Lab. Clin. Med. 128:1996;242
12. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol. 10:1997;503
13. Bennett A. The production of prostanoids in human cancers, and their implications for tumor progression. Prog. Lipid Res. 25:1986;539
14. Subbaramaiah K., Telang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56:1996;4424
15. Singh A., Purohit A., Ghilchik M.W., Reed M.J. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr. Relat. Cancer. 6:1999;139
16. Rozic J.G., Chakraborty C., Lala P.K. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer. 93:2001;497
17. Timoshenko A.V., Xu G., Chakrabarti S., Lala P.K., Chakraborty C. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Exp. Cell Res. 289:2003;265
18. Liu X.H., Rose D.P. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res. 56:1996;5125
19. Platet N., Prevostel C., Derocq D., Joubert D., Rochefort H., Garcia M. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int. J. Cancer. 75:1998;750
20. Dertinger S.A., Torous D.K., Tometsko A.M. Modulation of phorbol ester-induced HL-60 differentiation by prostaglandin E2. Mutat. Res. 328:1995;55
21. Kugler A., Hemmerlein B., Thelen P., Kallerhoff M., Radzun H.J., Ringert R.H. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J. Urol. 160:1998;1914
22. Konger R.L., Malaviya R., Pentland A.P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta. 1401:1998;221
23. Belley A., Chadee K. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology. 117:1999;1352
24. Makela M., Salo T., Larjava H. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Biochem. Biophys. Res. Commun. 253:1998;325
25. Goetzl E.J., An S., Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9:1995;1051
26. Nabeshima K., Inoue T., Shimao Y., Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52:2002;255
27. Lev S., Gilburd B., Lahat N., Shoenfeld Y. Prevention of tumor spread by matrix metalloproteinase-9 inhibition: old drugs, new concept. Eur. J. Intern. Med. 13:2002;101
28. Zeng L., An S., Goetzl E.J. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. J. Biol. Chem. 271:1996;27744
29. Tsuboi K., Sugimoto Y., Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat. 68-69:2002;535
30. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109
31. Dempke W., Rie C., Grothey A., Schmoll H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol. 127:2002;411
32. Kitahara M., Ichikawa M., Kinoshita T., Shiozawa S., Shigematsu H., Komiyama A. Prostacyclin inhibits the production of MMP-9 induced by phorbol ester through protein kinase A activation, but does not affect the production of MMP-2 in human cultured mesangial cells. Kidney Blood Press. Res. 24:2001;18
33. Wilson J.W., Potten C.S. The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice. Cancer Res. 60:2000;4645
34. Bhattacharya M., Peri K.G., Almazan G., Ribeiro-da-Silva A., Shichi H., Durocher Y., et al. Nuclear localization of prostaglandin E2 receptors. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15792
35. Schrey M.P., Patel K.V. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts, regulation by inflammatory mediators. Br. J. Cancer. 72:1995;1412
36. Wang T.N., Albo D., Tuszynski G.P. Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery. 132:2002;220
37. Sargiannidou I., Zhou J., Tuszynski G.P. The role of thrombospondin-1 in tumor progression. Exp. Biol. Med. (Maywood). 226:2001;726
38. Chen J., Parsons S., Brautigan D.L. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269:1994;7957
39. Jakes J, Schlender KK. Histone H1 phosphorylated by protein kinase C is a selective substrate for the assay of protein phosphatase 2A in the presence of phosphatase 1. Biochim Biophys Acta 1988;11.
40. Gopalakrishna R., Gundimeda U., Fontana J.A., Clarke R. Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status. Cancer Lett. 136:1999;143
41. Feschenko M.S., Stevenson E., Nairn A.C., Sweadner K.J. A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J. Pharmacol. Exp. Ther. 302:2002;111